Literature DB >> 31578648

Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.

Rui Zhao1, Yilin Wang1, Wei Zhou1, Jiaxin Guo1, Mei He1, Ping Li2, Jianlin Gao3, Zhifeng Gu4,5,6, Chen Dong7,8.   

Abstract

OBJECTIVE: The main purpose of this study was to investigate the current situation of primary Sjögren's syndrome (pSS) patients with interstitial lung disease (ILD) in China. The relationships between social demography, disease activity, psychological status, clinical variables, and ILD were analyzed. Besides that, the quality of life (QoL) in pSS with ILD was also analyzed.
METHODS: In the cross-sectional study, 101 pSS patients participated in this study. Under the guidance of the researchers, the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI), EULAR Sjögren's Syndrome Patient-Reported Index (ESSPRI), the Short-Form 36 health survey (SF-36), Hospital Anxiety and Depression Scale (HADS), Pittsburgh sleep quality index (PSQI), Summated Xerostomia Inventory (SXI), and other related questionnaires were completed. Independent sample t tests, Mann-Whitney U test, chi-square test, and correlational analysis were used.
RESULTS: The data showed that 28 (30.1%) pSS people with ILD. The occurrence and development of ILD were associated with disease duration, fatigue, alanine aminotransferase (ALT), neutrophils, albumin, and use of hormone. The survey also found that the QoL of pSS-ILD was significantly lower than non-ILD, especially the score in the dimension of role physical function.
CONCLUSIONS: ILD was very common in pSS. ILD had a significant negative impact on the QoL of patients. Therefore, it is of great significance to strengthen the early intervention and drug treatment of pSS patients to prevent ILD and improve their QoL.Key Points• This cross-sectional study finds that the incidence of ILD in patients with pSS is 30.1%.• The occurrence and development of ILD is associated with disease duration, fatigue, alanine aminotransferase (ALT), neutrophils, albumin, and use of hormone.•The study also finds that the QoL of pSS-ILD is significantly lower than in patients with non-ILD, especially the score in the dimension of role physical function.

Entities:  

Keywords:  China; Interstitial lung disease; Primary Sjögren’s syndrome; Quality of life

Mesh:

Year:  2019        PMID: 31578648     DOI: 10.1007/s10067-019-04753-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

1.  Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome.

Authors:  Christos F Kampolis; Sofia Fragkioudaki; Clio P Mavragani; Alexandra Zormpala; Anastasia Samakovli; Haralampos M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  2018-05-29       Impact factor: 4.473

2.  Sleep quality in patients with primary Sjögren's syndrome.

Authors:  Roberta Priori; Antonina Minniti; Barbara Antonazzo; Massimo Fusconi; Guido Valesini; Giuseppe Curcio
Journal:  Clin Exp Rheumatol       Date:  2016-04-15       Impact factor: 4.473

3.  Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort study.

Authors:  Ming-Han Chen; Chun-Ku Chen; Hsiao-Ping Chou; Ming-Huang Chen; Chang-Youh Tsai; Deh-Ming Chang
Journal:  Clin Exp Rheumatol       Date:  2016-08-31       Impact factor: 4.473

  3 in total
  6 in total

1.  Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.

Authors:  Shi-Hao He; Yu-Jie He; Kuang-Jin Guo; Xu Liang; Shan-Shan Li; Tian-Fang Li
Journal:  Clin Rheumatol       Date:  2021-11-10       Impact factor: 2.980

2.  Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.

Authors:  Ting Guo; Yaomei Long; Qinxue Shen; Wei Guo; Wang Duan; Xiaoli Ouyang; Hong Peng
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

3.  Associated factors with constipation and health-related quality of life in lung cancer patients with platinum-based chemotherapy: A cross-sectional study.

Authors:  Huamao Chen; Xixi Gu; Yan Zhang; Jian Feng; Yan Gu
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

4.  National Sjögren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.

Authors:  Sara S McCoy; Christie M Bartels; Ian J Saldanha; Vatinee Y Bunya; Esen K Akpek; Matthew A Makara; Alan N Baer
Journal:  J Rheumatol       Date:  2020-09-15       Impact factor: 5.346

5.  Interstitial lung disease in Primary Sjögren's syndrome.

Authors:  Wei Lin; Zhifei Xin; Jianlong Zhang; Ning Liu; Xiuying Ren; Meilu Liu; Yashuang Su; Yixuan Liu; Liu Yang; Shaoying Guo; Yupeng Yang; Yang Li; Jingjing Cao; Xiaoran Ning; Jingjing Li; He Xue; Nannan Niu; Yingmin Chen; Fang Li; Lijun Sun; Xiaopeng Zhang; Fengxiao Zhang; Wen Zhang
Journal:  BMC Pulm Med       Date:  2022-02-27       Impact factor: 3.317

6.  Machine learning based on metabolomics reveals potential targets and biomarkers for primary Sjogren's syndrome.

Authors:  Kai Wang; Ju Li; Deqian Meng; Zhongyuan Zhang; Shanshan Liu
Journal:  Front Mol Biosci       Date:  2022-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.